NCT00054288View on ClinicalTrials.gov

Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2001

Primary Completion Date

May 31, 2003

Study Completion Date

June 30, 2009

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

gemcitabine hydrochloride

DRUG

irinotecan hydrochloride

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00054288 - Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors | Biotech Hunter | Biotech Hunter